Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures -- Ignore unavailable to you. Want to Upgrade?

To: ~digs who wrote (1515)	9/19/2005 6:09:30 PM
From: ~digs	Read Replies (1) \| Respond to of 7944

StemCells Inc. (STEM) said Monday evening that results from a published study demonstrate that its proprietary human neural stem cells restore the lost motor function of mice with spinal cord injuries. The Palo Alto, Calif.-based company said as part of the study conducted at the University of California, Irvine, human neural stem cells were transplanted into mice nine days after a spinal cord crush injury that resulted in hind limb paralysis. The mice were then observed and tested for 16 weeks after the transplant, and the transplanted mice showed significant improvement in their ability to walk compared to mice in two control groups. The improvement persisted during the full term of the study. [STEM] STEMCELLS INC » 6.00 +1.1 ( +22.45%) 6:08pm ET